EIEE39
MCID: EPL185
MIFTS: 31

Epileptic Encephalopathy, Early Infantile, 39 (EIEE39)

Categories: Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Epileptic Encephalopathy, Early Infantile, 39

MalaCards integrated aliases for Epileptic Encephalopathy, Early Infantile, 39:

Name: Epileptic Encephalopathy, Early Infantile, 39 58 76
Hypomyelination, Global Cerebral 58 76 30 13 6 41 74
Agc1 Deficiency 58 12 60 76
Epileptic Encephalopathy with Global Cerebral Demyelination 12 60
Hereditary Central Nervous System Demyelinating Diseases 45 74
Early Infantile Epileptic Encephalopathy 39 12 15
Aspartate-Glutamate Carrier 1 Deficiency 58 76
Global Cerebral Hypomyelination 76 38
Eiee39 58 76
Mitochondrial Aspartate-Glutamate Carrier 1 Deficiency 60

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
onset in infancy
two unrelated families have been reported (last curated july 2016)


HPO:

33
epileptic encephalopathy, early infantile, 39:
Onset and clinical course infantile onset
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:0080349
OMIM 58 612949
KEGG 38 H01305
ICD10 via Orphanet 35 G31.8
Orphanet 60 ORPHA353217
MedGen 43 C2751855

Summaries for Epileptic Encephalopathy, Early Infantile, 39

UniProtKB/Swiss-Prot : 76 Epileptic encephalopathy, early infantile, 39: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE39 is characterized by global hypomyelination of the central nervous system, with the gray matter appearing relatively unaffected. Inheritance is autosomal recessive.

MalaCards based summary : Epileptic Encephalopathy, Early Infantile, 39, also known as hypomyelination, global cerebral, is related to epilepsy, and has symptoms including seizures and muscle spasticity. An important gene associated with Epileptic Encephalopathy, Early Infantile, 39 is SLC25A12 (Solute Carrier Family 25 Member 12), and among its related pathways/superpathways is Glucose / Energy Metabolism. Affiliated tissues include eye and brain, and related phenotypes are seizures and spasticity

Disease Ontology : 12 An early infantile epileptic encephalopathy that has material basis in mutation in the SLC25A12 gene on chromosome 2q31.

Description from OMIM: 612949

Related Diseases for Epileptic Encephalopathy, Early Infantile, 39

Diseases in the Early Infantile Epileptic Encephalopathy family:

Epileptic Encephalopathy, Early Infantile, 9 Epileptic Encephalopathy, Early Infantile, 8
Epileptic Encephalopathy, Early Infantile, 2 Epileptic Encephalopathy, Early Infantile, 36
Epileptic Encephalopathy, Early Infantile, 1 Epileptic Encephalopathy, Early Infantile, 6
Epileptic Encephalopathy, Early Infantile, 3 Epileptic Encephalopathy, Early Infantile, 4
Epileptic Encephalopathy, Early Infantile, 39 Epileptic Encephalopathy, Early Infantile, 5
Epileptic Encephalopathy, Early Infantile, 7 Epileptic Encephalopathy, Early Infantile, 11
Epileptic Encephalopathy, Early Infantile, 12 Epileptic Encephalopathy, Early Infantile, 13
Epileptic Encephalopathy, Early Infantile, 14 Epileptic Encephalopathy, Early Infantile, 15
Epileptic Encephalopathy, Early Infantile, 16 Epileptic Encephalopathy, Early Infantile, 17
Epileptic Encephalopathy, Early Infantile, 18 Epileptic Encephalopathy, Early Infantile, 19
Epileptic Encephalopathy, Early Infantile, 21 Epileptic Encephalopathy, Early Infantile, 23
Epileptic Encephalopathy, Early Infantile, 24 Epileptic Encephalopathy, Early Infantile, 26
Epileptic Encephalopathy, Early Infantile, 27 Epileptic Encephalopathy, Early Infantile, 28
Epileptic Encephalopathy, Early Infantile, 29 Epileptic Encephalopathy, Early Infantile, 30
Epileptic Encephalopathy, Early Infantile, 31 Epileptic Encephalopathy, Early Infantile, 32
Epileptic Encephalopathy, Early Infantile, 33 Epileptic Encephalopathy, Early Infantile, 50
Epileptic Encephalopathy, Early Infantile, 34 Epileptic Encephalopathy, Early Infantile, 35
Epileptic Encephalopathy, Early Infantile, 37 Epileptic Encephalopathy, Early Infantile, 38
Epileptic Encephalopathy, Early Infantile, 40 Epileptic Encephalopathy, Early Infantile, 41
Epileptic Encephalopathy, Early Infantile, 42 Epileptic Encephalopathy, Early Infantile, 43
Epileptic Encephalopathy, Early Infantile, 44 Epileptic Encephalopathy, Early Infantile, 45
Epileptic Encephalopathy, Early Infantile, 46 Epileptic Encephalopathy, Early Infantile, 47
Epileptic Encephalopathy, Early Infantile, 48 Epileptic Encephalopathy, Early Infantile, 49
Epileptic Encephalopathy, Early Infantile, 51 Epileptic Encephalopathy, Early Infantile, 52
Epileptic Encephalopathy, Early Infantile, 53 Epileptic Encephalopathy, Early Infantile, 54
Epileptic Encephalopathy, Early Infantile, 55 Epileptic Encephalopathy, Early Infantile, 56
Epileptic Encephalopathy, Early Infantile, 57 Epileptic Encephalopathy, Early Infantile, 58
Epileptic Encephalopathy, Early Infantile, 59 Epileptic Encephalopathy, Early Infantile, 60
Epileptic Encephalopathy, Early Infantile, 61 Epileptic Encephalopathy, Early Infantile, 62
Epileptic Encephalopathy, Early Infantile, 63 Epileptic Encephalopathy, Early Infantile, 64
Epileptic Encephalopathy, Early Infantile, 65 Epileptic Encephalopathy, Early Infantile, 66
Epileptic Encephalopathy, Early Infantile, 67 Epileptic Encephalopathy, Early Infantile, 68
Epileptic Encephalopathy, Early Infantile, 69 Epileptic Encephalopathy, Early Infantile, 70
Epileptic Encephalopathy, Early Infantile, 71

Diseases related to Epileptic Encephalopathy, Early Infantile, 39 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 epilepsy 10.1

Symptoms & Phenotypes for Epileptic Encephalopathy, Early Infantile, 39

Human phenotypes related to Epileptic Encephalopathy, Early Infantile, 39:

33 (show all 9)
# Description HPO Frequency HPO Source Accession
1 seizures 33 HP:0001250
2 spasticity 33 HP:0001257
3 hyperreflexia 33 HP:0001347
4 global developmental delay 33 HP:0001263
5 absent speech 33 HP:0001344
6 severe muscular hypotonia 33 HP:0006829
7 epileptic encephalopathy 33 HP:0200134
8 poor eye contact 33 HP:0000817
9 cerebral hypomyelination 33 HP:0006808

Symptoms via clinical synopsis from OMIM:

58
Neurologic Central Nervous System:
seizures
spasticity
hyperreflexia
epileptic encephalopathy
delayed psychomotor development, profound
more
Muscle Soft Tissue:
hypotonia, severe

Laboratory Abnormalities:
increased plasma lactate

Head And Neck Eyes:
poor eye contact

Respiratory:
apneic spells

Clinical features from OMIM:

612949

UMLS symptoms related to Epileptic Encephalopathy, Early Infantile, 39:


seizures, muscle spasticity

Drugs & Therapeutics for Epileptic Encephalopathy, Early Infantile, 39

Search Clinical Trials , NIH Clinical Center for Epileptic Encephalopathy, Early Infantile, 39

Cochrane evidence based reviews: hereditary central nervous system demyelinating diseases

Genetic Tests for Epileptic Encephalopathy, Early Infantile, 39

Genetic tests related to Epileptic Encephalopathy, Early Infantile, 39:

# Genetic test Affiliating Genes
1 Hypomyelination, Global Cerebral 30 SLC25A12

Anatomical Context for Epileptic Encephalopathy, Early Infantile, 39

MalaCards organs/tissues related to Epileptic Encephalopathy, Early Infantile, 39:

42
Eye, Brain

Publications for Epileptic Encephalopathy, Early Infantile, 39

Articles related to Epileptic Encephalopathy, Early Infantile, 39:

# Title Authors Year
1
ARALAR/AGC1 deficiency, a neurodevelopmental disorder with severe impairment of neuronal mitochondrial respiration, does not produce a primary increase in brain lactate. ( 28429368 )
2017
2
AGC1 deficiency causes infantile epilepsy, abnormal myelination, and reduced n-acetylaspartate. ( 24515575 )
2014
3
AGC1 deficiency associated with global cerebral hypomyelination. ( 19641205 )
2009

Variations for Epileptic Encephalopathy, Early Infantile, 39

UniProtKB/Swiss-Prot genetic disease variations for Epileptic Encephalopathy, Early Infantile, 39:

76
# Symbol AA change Variation ID SNP ID
1 SLC25A12 p.Gln590Arg VAR_063253 rs121434396
2 SLC25A12 p.Arg353Gln VAR_071976 rs886037851

ClinVar genetic disease variations for Epileptic Encephalopathy, Early Infantile, 39:

6 (show top 50) (show all 74)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC25A12 NM_003705.4(SLC25A12): c.1769A> G (p.Gln590Arg) single nucleotide variant Pathogenic rs121434396 GRCh37 Chromosome 2, 172644147: 172644147
2 SLC25A12 NM_003705.4(SLC25A12): c.1769A> G (p.Gln590Arg) single nucleotide variant Pathogenic rs121434396 GRCh38 Chromosome 2, 171787637: 171787637
3 SLC25A12 NM_003705.4(SLC25A12): c.728G> A (p.Arg243Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs35881803 GRCh37 Chromosome 2, 172691260: 172691260
4 SLC25A12 NM_003705.4(SLC25A12): c.728G> A (p.Arg243Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs35881803 GRCh38 Chromosome 2, 171834750: 171834750
5 SLC25A12 NM_003705.4(SLC25A12): c.1058G> A (p.Arg353Gln) single nucleotide variant Pathogenic rs886037851 GRCh38 Chromosome 2, 171813452: 171813452
6 SLC25A12 NM_003705.4(SLC25A12): c.1058G> A (p.Arg353Gln) single nucleotide variant Pathogenic rs886037851 GRCh37 Chromosome 2, 172669962: 172669962
7 SLC25A12 NM_003705.4(SLC25A12): c.*1281G> A single nucleotide variant Uncertain significance rs746811339 GRCh38 Chromosome 2, 171783993: 171783993
8 SLC25A12 NM_003705.4(SLC25A12): c.*1281G> A single nucleotide variant Uncertain significance rs746811339 GRCh37 Chromosome 2, 172640503: 172640503
9 SLC25A12 NM_003705.4(SLC25A12): c.*995G> A single nucleotide variant Uncertain significance rs886055122 GRCh38 Chromosome 2, 171784279: 171784279
10 SLC25A12 NM_003705.4(SLC25A12): c.*995G> A single nucleotide variant Uncertain significance rs886055122 GRCh37 Chromosome 2, 172640789: 172640789
11 SLC25A12 NM_003705.4(SLC25A12): c.*739G> C single nucleotide variant Likely benign rs11757 GRCh38 Chromosome 2, 171784535: 171784535
12 SLC25A12 NM_003705.4(SLC25A12): c.*739G> C single nucleotide variant Likely benign rs11757 GRCh37 Chromosome 2, 172641045: 172641045
13 SLC25A12 NM_003705.4(SLC25A12): c.1665G> A (p.Thr555=) single nucleotide variant Uncertain significance rs145746525 GRCh38 Chromosome 2, 171787868: 171787868
14 SLC25A12 NM_003705.4(SLC25A12): c.1665G> A (p.Thr555=) single nucleotide variant Uncertain significance rs145746525 GRCh37 Chromosome 2, 172644378: 172644378
15 SLC25A12 NM_003705.4(SLC25A12): c.1338A> C (p.Pro446=) single nucleotide variant Conflicting interpretations of pathogenicity rs149278617 GRCh38 Chromosome 2, 171793735: 171793735
16 SLC25A12 NM_003705.4(SLC25A12): c.1338A> C (p.Pro446=) single nucleotide variant Conflicting interpretations of pathogenicity rs149278617 GRCh37 Chromosome 2, 172650245: 172650245
17 SLC25A12 NM_003705.4(SLC25A12): c.99T> C (p.Tyr33=) single nucleotide variant Benign rs1878583 GRCh38 Chromosome 2, 171868791: 171868791
18 SLC25A12 NM_003705.4(SLC25A12): c.99T> C (p.Tyr33=) single nucleotide variant Benign rs1878583 GRCh37 Chromosome 2, 172725301: 172725301
19 SLC25A12 NM_003705.4(SLC25A12): c.13G> A (p.Val5Met) single nucleotide variant Uncertain significance rs201557997 GRCh38 Chromosome 2, 171893258: 171893258
20 SLC25A12 NM_003705.4(SLC25A12): c.13G> A (p.Val5Met) single nucleotide variant Uncertain significance rs201557997 GRCh37 Chromosome 2, 172749768: 172749768
21 SLC25A12 NM_003705.4(SLC25A12): c.*1251A> G single nucleotide variant Uncertain significance rs886055121 GRCh38 Chromosome 2, 171784023: 171784023
22 SLC25A12 NM_003705.4(SLC25A12): c.*1251A> G single nucleotide variant Uncertain significance rs886055121 GRCh37 Chromosome 2, 172640533: 172640533
23 SLC25A12 NM_003705.4(SLC25A12): c.*694G> C single nucleotide variant Uncertain significance rs113965617 GRCh38 Chromosome 2, 171784580: 171784580
24 SLC25A12 NM_003705.4(SLC25A12): c.*694G> C single nucleotide variant Uncertain significance rs113965617 GRCh37 Chromosome 2, 172641090: 172641090
25 SLC25A12 NM_003705.4(SLC25A12): c.*72T> A single nucleotide variant Uncertain significance rs779748917 GRCh38 Chromosome 2, 171785202: 171785202
26 SLC25A12 NM_003705.4(SLC25A12): c.*72T> A single nucleotide variant Uncertain significance rs779748917 GRCh37 Chromosome 2, 172641712: 172641712
27 SLC25A12 NM_003705.4(SLC25A12): c.1909G> A (p.Gly637Ser) single nucleotide variant Uncertain significance rs772668725 GRCh38 Chromosome 2, 171785402: 171785402
28 SLC25A12 NM_003705.4(SLC25A12): c.1909G> A (p.Gly637Ser) single nucleotide variant Uncertain significance rs772668725 GRCh37 Chromosome 2, 172641912: 172641912
29 SLC25A12 NM_003705.4(SLC25A12): c.1458G> A (p.Ala486=) single nucleotide variant Conflicting interpretations of pathogenicity rs142179562 GRCh38 Chromosome 2, 171791578: 171791578
30 SLC25A12 NM_003705.4(SLC25A12): c.1458G> A (p.Ala486=) single nucleotide variant Conflicting interpretations of pathogenicity rs142179562 GRCh37 Chromosome 2, 172648088: 172648088
31 SLC25A12 NM_003705.4(SLC25A12): c.-55C> T single nucleotide variant Uncertain significance rs886055126 GRCh38 Chromosome 2, 171894269: 171894269
32 SLC25A12 NM_003705.4(SLC25A12): c.-55C> T single nucleotide variant Uncertain significance rs886055126 GRCh37 Chromosome 2, 172750779: 172750779
33 SLC25A12 NM_003705.4(SLC25A12): c.-57_-56dupGC duplication Uncertain significance rs759200327 GRCh38 Chromosome 2, 171894270: 171894271
34 SLC25A12 NM_003705.4(SLC25A12): c.-57_-56dupGC duplication Uncertain significance rs759200327 GRCh37 Chromosome 2, 172750780: 172750781
35 SLC25A12 NM_003705.4(SLC25A12): c.*1050G> A single nucleotide variant Likely benign rs17499544 GRCh38 Chromosome 2, 171784224: 171784224
36 SLC25A12 NM_003705.4(SLC25A12): c.*1050G> A single nucleotide variant Likely benign rs17499544 GRCh37 Chromosome 2, 172640734: 172640734
37 SLC25A12 NM_003705.4(SLC25A12): c.*994C> T single nucleotide variant Uncertain significance rs189758490 GRCh38 Chromosome 2, 171784280: 171784280
38 SLC25A12 NM_003705.4(SLC25A12): c.*994C> T single nucleotide variant Uncertain significance rs189758490 GRCh37 Chromosome 2, 172640790: 172640790
39 SLC25A12 NM_003705.4(SLC25A12): c.*988C> T single nucleotide variant Uncertain significance rs138037221 GRCh38 Chromosome 2, 171784286: 171784286
40 SLC25A12 NM_003705.4(SLC25A12): c.*988C> T single nucleotide variant Uncertain significance rs138037221 GRCh37 Chromosome 2, 172640796: 172640796
41 SLC25A12 NM_003705.4(SLC25A12): c.*124G> A single nucleotide variant Uncertain significance rs13035825 GRCh38 Chromosome 2, 171785150: 171785150
42 SLC25A12 NM_003705.4(SLC25A12): c.*124G> A single nucleotide variant Uncertain significance rs13035825 GRCh37 Chromosome 2, 172641660: 172641660
43 SLC25A12 NM_003705.4(SLC25A12): c.1468C> T (p.Arg490Ter) single nucleotide variant Uncertain significance rs762189046 GRCh38 Chromosome 2, 171791568: 171791568
44 SLC25A12 NM_003705.4(SLC25A12): c.1468C> T (p.Arg490Ter) single nucleotide variant Uncertain significance rs762189046 GRCh37 Chromosome 2, 172648078: 172648078
45 SLC25A12 NM_003705.4(SLC25A12): c.1418G> A (p.Arg473Gln) single nucleotide variant Conflicting interpretations of pathogenicity rs35565687 GRCh38 Chromosome 2, 171793655: 171793655
46 SLC25A12 NM_003705.4(SLC25A12): c.1418G> A (p.Arg473Gln) single nucleotide variant Conflicting interpretations of pathogenicity rs35565687 GRCh37 Chromosome 2, 172650165: 172650165
47 SLC25A12 NM_003705.4(SLC25A12): c.466-3C> T single nucleotide variant Likely benign rs3765166 GRCh38 Chromosome 2, 171837270: 171837270
48 SLC25A12 NM_003705.4(SLC25A12): c.466-3C> T single nucleotide variant Likely benign rs3765166 GRCh37 Chromosome 2, 172693780: 172693780
49 SLC25A12 NM_003705.4(SLC25A12): c.189A> G (p.Val63=) single nucleotide variant Uncertain significance rs756682372 GRCh38 Chromosome 2, 171868701: 171868701
50 SLC25A12 NM_003705.4(SLC25A12): c.189A> G (p.Val63=) single nucleotide variant Uncertain significance rs756682372 GRCh37 Chromosome 2, 172725211: 172725211

Expression for Epileptic Encephalopathy, Early Infantile, 39

Search GEO for disease gene expression data for Epileptic Encephalopathy, Early Infantile, 39.

Pathways for Epileptic Encephalopathy, Early Infantile, 39

Pathways related to Epileptic Encephalopathy, Early Infantile, 39 according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.11 SLC25A12 UCP2

GO Terms for Epileptic Encephalopathy, Early Infantile, 39

Cellular components related to Epileptic Encephalopathy, Early Infantile, 39 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mitochondrion GO:0005739 9.13 MTCH1 SLC25A12 UCP2
2 mitochondrial inner membrane GO:0005743 8.8 MTCH1 SLC25A12 UCP2

Sources for Epileptic Encephalopathy, Early Infantile, 39

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....